
Advos
Advos.io
@advos
31341 articles
Articles

CNS Pharmaceuticals Highlights Oversubscribed $22.5 Million Financing, Growth Strategy in Investor Presentation
CNS Pharmaceuticals discusses its oversubscribed $22.5 million financing and strategic reset, indicating strong institutional investor confidence and a strengthened balance sheet for pursuing transformative opportunities.
June 8, 2026Read the full article

Tonix Pharmaceuticals Expands TONMYA Coverage to 52 Million Commercial Lives
Tonix Pharmaceuticals announced a coverage agreement with a second major group purchasing organization, expanding TONMYA's commercial access to 52 million lives, representing about 29% of U.S. commercially insured individuals.
June 8, 2026Read the full article

Regentis Biomaterials to Launch Surgeon Training for GelrinC in Europe
Regentis Biomaterials plans to begin European surgeon training in Q3 2026 for its CE Mark-approved GelrinC knee cartilage implant, advancing commercialization.
June 8, 2026Read the full article

Gold Price Drivers Shift as Monetary Policy Takes Center Stage
Gold prices have stalled after record highs, with monetary policy now exerting a disproportionate impact on the trajectory of the precious metal, prompting investors to recalibrate their strategies.
June 8, 2026Read the full article

Redwood AI Corp. Emerges as a Key Player in AI, Defense, and Post-Quantum Cybersecurity
Redwood AI Corp., with a proprietary AI platform and growing Canadian government partnerships, is positioning itself at the intersection of AI, defense technology, and post-quantum cybersecurity, potentially offering significant growth in mission-critical sectors.
June 8, 2026Read the full article

Businesses Lag in AI Readiness as Adoption Accelerates Across Industries
A new analysis reveals that many businesses are unprepared for the rapid transition to artificial intelligence, despite growing adoption in sectors like online gaming.
June 8, 2026Read the full article

Radioactive Collagen Tiles Show Promise in Preventing Brain Cancer Recurrence, Trial Finds
A clinical trial called ROADS, presented at the 2026 ASCO meeting by MD Anderson Cancer Center, showed that placing radioactive collagen tiles in the brain cavity after tumor removal significantly reduces recurrence and extends survival.
June 8, 2026Read the full article

Xeriant's NexBoard Achieves Highest ASTM E84 Class A Fire Rating, Paving Way for Commercialization
Xeriant's NexBoard fire-resistant construction panel attains the top Class A fire rating in ASTM E84 testing, expected to accelerate commercialization and convert a backlog of potential customers.
June 8, 2026Read the full article

Puerto Rico's Day at the Ballpark Returns for 2026, Honoring Francisco Lindor at Citi Field
The 2026 edition of Puerto Rico's Day at the Ballpark launches June 9 at Citi Field, celebrating the island's baseball legacy with cultural activations and a tribute to Mets star Francisco Lindor, as the series has generated over 6 billion impressions and attracted half a million attendees since its inception.
June 8, 2026Read the full article

Redwood AI Corp. Positions as Mission-Critical AI and Cybersecurity Platform Amid Expanding Government, Defense Opportunities
Redwood AI Corp. is emerging as a specialized AI platform serving government, defense, and healthcare markets, with partnerships in Canada and a proposed quantum cybersecurity acquisition.
June 8, 2026Read the full article

Midwest Industrial Buildings: A 10-Minute Evaluation for Edge Data Center Conversion
Logan Freeman of Midwest CRE Advisors shares a repeatable process for evaluating industrial buildings for edge data center conversion, focusing on electrical infrastructure, floor load, cooling, and prior use, which can compress deployment timelines and reduce costs.
June 8, 2026Read the full article

Developer Daniel Kaufman Shifts from Complexity to Simplicity, Focusing on Smaller, Clearer Deals
Daniel Kaufman, founder of Kaufman & Company, is recalibrating his real estate development strategy toward simpler, mission-aligned projects he can explain in two sentences, arguing that smaller deals can yield better returns with less risk.
June 8, 2026Read the full article

Quantum BioPharma Advances LUCID-MS Therapy for Multiple Sclerosis After Positive Phase 1 Results
Quantum BioPharma announced the completion of Phase 1 clinical studies for LUCID-MS, a therapy targeting myelin repair in multiple sclerosis, and submitted an Investigational New Drug application to the FDA.
June 8, 2026Read the full article

TransCode Therapeutics to Host R&D Webcast on Phase 2a Trial for Colorectal Cancer
TransCode Therapeutics will host its first R&D webcast on June 18, 2026, to discuss its Phase 2a trial of TTX-MC138 in colorectal cancer and broader pipeline updates.
June 8, 2026Read the full article

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance ONC010, Appoints VP of Corporate Finance
Onco-Innovations Limited has signed a non-binding letter of intent with Nanosoft Polymers to support development of its oncology candidate ONC010 and appointed Dave Antony as vice president of corporate finance.
June 8, 2026Read the full article

Safe Pro Group Delivers AI-Powered Threat Detection System Under U.S. Army Contract
Safe Pro Group Inc. has fulfilled a $743,000 U.S. Army order for its AI-powered Threat Analysis Kit, integrating drones and edge computing to rapidly identify explosive threats and generate battlefield maps.
June 8, 2026Read the full article

Oncotelic Therapeutics to Highlight AI Drug Discovery Platform at Qdrant Vector Space Day 2026
Oncotelic Therapeutics will showcase its PDAOAI platform, built on Qdrant infrastructure, which accelerated two drug candidates from concept to IND filings in under two years, demonstrating a major reduction in time and cost for pharmaceutical development.
June 8, 2026Read the full article

Ladybug Resource Group Highlights CEO's Lean Manufacturing Expertise for EV Supply Chain
Ladybug Resource Group, Inc. emphasizes the leadership of Shicai Li, whose experience in Toyota, Honda, and Panasonic production systems underpins the company's AI-driven manufacturing strategy for the global electric vehicle market.
June 8, 2026Read the full article

MAX Power Mining Sells Arizona Lithium Asset to Focus on Natural Hydrogen
MAX Power Mining Corp. divests its Willcox Playa Lithium Project to Homeland Critical Minerals Corp. for $1.1 million in shares, sharpening its focus on natural hydrogen exploration in Saskatchewan.
June 8, 2026Read the full article

MAX Power Mining Divests Arizona Lithium Asset to Focus on Natural Hydrogen
MAX Power Mining Corp. sells its Willcox Playa Lithium Project in Arizona to Homeland Critical Minerals Corp. for 11 million shares, sharpening its focus on natural hydrogen exploration in Saskatchewan.
June 8, 2026Read the full article

McEwen Mining's Grey Fox Pre-Feasibility Study Shows Potential to Boost Fox Complex Output to 100,000 Ounces by 2029
McEwen Mining announced positive pre-feasibility study results for its Grey Fox project, projecting significant production increases and extended mine life at the Fox Complex.
June 8, 2026Read the full article
